Ashok Kumar Pandurangan | Tissue Engineering | Excellence in Research

Published on by Mechanics Awards

Dr. Ashok Kumar Pandurangan | Tissue Engineering | Excellence in Research

Associate Professor | B.S. Abdur Rahman Crescent Institute of Science and Technology | India

Dr. Ashok Kumar Pandurangan is an accomplished biochemist and cancer researcher with over a decade of academic and research experience across India, the United States, and Malaysia. He is currently serving as an Associate Professor in the School of Life Sciences at B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, since . His expertise lies in molecular oncology, particularly focusing on colon and breast cancers, ulcerative colitis, and cancer therapeutics. His career is marked by significant contributions to drug development, screening methods, and the exploration of natural products in cancer prevention and treatment. With post-doctoral research experience at prestigious institutions such as Children’s Hospital Oakland Research Institute (USA), Universiti Putra Malaysia, and the University of Malaya, he has developed strong international collaborations and research credentials. Passionate about innovation, he continues to integrate fundamental cancer biology with translational approaches aimed at discovering novel and effective therapeutic strategies.

Professional Profile

Scholar

Education

Dr. Ashok Kumar Pandurangan holds a strong academic background in biochemistry, marked by excellence in both coursework and research. He began his academic journey with a B.Sc. in Biochemistry followed by an M.Sc. in Biochemistry  at Islamiah College, affiliated with the University of Madras, where he graduated with distinctions. He then pursued an M.Phil. in Biochemistry at the University of Madras. His passion for cancer biology led him to a Ph.D. in Biochemistry at the University of Madras, Guindy Campus, where he graduated with high commendation. His doctoral research, centered on luteolin’s protective role in colon cancer, provided deep insights into the modulation of key signaling pathways, including Wnt/β-catenin, angiogenesis, apoptosis, and oxidative stress. This academic foundation prepared him for impactful global research and teaching contributions in oncology.

Experience

Dr. Ashok Kumar Pandurangan has accumulated extensive professional experience in teaching and research, spanning globally recognized institutions. He began his post-doctoral career at the Children’s Hospital Oakland Research Institute where he studied the role of sphingolipid metabolism in colon cancer progression. Later, as a Post-Doctoral Fellow at Universiti Putra Malaysia, he investigated nanomaterials for cancer therapy, bioflavonoids in autophagy, and dietary components like rice bran derivatives for cancer prevention. He then joined the University of Malaya as a Visiting Research Fellow, contributing to cancer pharmacology and drug screening studies. Since, he has been serving as an Associate Professor at B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, where he teaches biochemistry and life sciences while actively pursuing funded research projects. His diverse experience across continents reflects a blend of academic leadership, translational research, and innovative problem-solving in cancer therapeutics.

Research Focus

Dr. Ashok Kumar Pandurangan’s research focuses on cancer biology, molecular signaling, and translational therapeutics. His primary areas of investigation include signal transduction mechanisms in colon and breast cancers, ulcerative colitis, and colitis-associated cancers. His work emphasizes the chemopreventive and therapeutic potential of natural products, exploring compounds such as luteolin, green tea polyphenols, and rice bran derivatives in both in vitro and in vivo models. His post-doctoral research expanded into nanotechnology, evaluating nanomaterials for cancer therapy and drug delivery. Additionally, he has studied autophagy-mediated cell death in colorectal cancer and the role of sphingolipid metabolism in cancer progression. By targeting pathways like Wnt/β-catenin, Nrf2-ARE, TGF-β/Smad, and apoptotic signaling, his research bridges molecular biology with clinical applications. His multidisciplinary approach integrates biochemistry, pharmacology, and oncology, aiming to develop safe, effective, and innovative therapeutic strategies for cancer treatment and prevention.

Awards and Honors

Dr. Ashok Kumar Pandurangan has earned several recognitions throughout his career for academic excellence and research contributions in cancer biology. His Ph.D. thesis at the University of Madras was rated highlighting the novelty and impact of his work on luteolin in colon carcinogenesis. His achievements include securing prestigious international post-doctoral fellowships in the United States and Malaysia, enabling him to collaborate with leading scientists in oncology. He has received funding and project support for his research on nanomaterials, natural products, and cancer therapeutics. His global research exposure has resulted in numerous publications in reputed international journals, reflecting his scientific contributions to signal transduction, drug screening, and molecular oncology. In addition, he has been recognized for his active participation in international conferences and workshops, where he has presented his findings and built collaborations. These awards and honors underscore his standing as a respected researcher and educator in biochemistry and cancer research.

Publication Top Notes

Conclusion

The researcher demonstrates a strong research profile, with a focus on cancer research and a strong academic background. Their research experience and projects demonstrate their expertise in the field. With further evaluation of their publication record, citation impact, and collaboration, they could become an even stronger candidate for the Excellence in Research. Their contributions to the field of cancer research, and their potential for future research, make them a strong contender for this award.

Marcio Jose Concepcion-Zavaleta | Bio Materials | Young Scientist Award

Published on by Mechanics Awards

Dr. Marcio Jose Concepcion-Zavaleta | Bio Materials | Young Scientist Award

Research | Universidad Científica del Sur | Peru

Dr. Marcio Jose Concepcion-Zavaleta is a Peruvian physician and endocrinologist, recognized for his outstanding academic and research achievements. He graduated as the top student at the Universidad Nacional de Trujillo, Faculty of Medicine, excelling throughout six years of medical training. He completed his internship at Hospital Nacional Edgardo Rebagliati Martins in Lima and later pursued residency training in Endocrinology at Hospital Nacional Guillermo Almenara Irigoyen – EsSalud. Currently, he serves as an endocrinologist at Javier Prado Clinic and Hospital Voto Bernales, while actively engaging in academic and clinical research. With more than indexed publications in Scopus, PubMed, and SciELO, he has contributed significantly to the literature on diabetes, thyroid disorders, obesity, and metabolic bone disease. A member of international and national endocrine societies, he also serves on editorial boards of leading journals and mentors young researchers, aiming to advance endocrinology through research and education.

Professional Profile

Orcid

Scholar

Education

Dr. Marcio Jose Concepcion-Zavaleta earned his Doctor of Medicine degree from the Universidad Nacional de Trujillo, Peru, where he consistently ranked first in his cohort of students across all six years of medical school. His excellence in academic performance was further demonstrated during his internship at Hospital Nacional Edgardo Rebagliati Martins, one of Peru’s most prestigious hospitals, where he gained comprehensive clinical experience. Driven by a passion for endocrinology, he pursued specialty training through a residency in Endocrinology at Hospital Nacional Guillermo Almenara Irigoyen – EsSalud in Lima, Peru. This residency provided him with specialized clinical expertise in managing complex endocrine disorders, including diabetes, thyroid disease, and metabolic bone conditions. His education extended beyond clinical practice to research, where he developed strong skills in scientific writing, systematic reviews, and evidence-based medicine. This educational foundation established him as both a skilled clinician and a prolific researcher.

Experience

Dr. Marcio Jose Concepcion-Zavaleta has built a solid career in both clinical endocrinology and academic research. Following his medical degree and residency, he began practicing as a specialist endocrinologist at Javier Prado Clinic and Hospital Voto Bernales in Lima, Peru, where he continues to provide expert care in diabetes, thyroid disorders, obesity, and bone metabolism. Beyond clinical duties, he has actively contributed to academia, serving as an Associate Researcher at Universidad Científica del Sur. His research portfolio includes more than  scientific articles, spanning systematic reviews, narrative reviews, case reports, descriptive studies, and analytical investigations, published in high-quality journals indexed in Scopus, PubMed, and SciELO. He has served as an editorial team member for the World Journal of Gastroenterology (Q1) and the Electronic Journal of General Medicine (Q3), contributing to peer review and editorial processes. He also mentors medical students and residents, emphasizing scientific writing and research methodology.

Research Focus

Dr. Marcio Jose Concepcion-Zavaleta focuses his research on diabetes mellitus, thyroid disorders, obesity, and metabolic bone diseases, with an emphasis on evidence-based medicine and clinical applicability. He has published extensively on the diagnosis, treatment, and management of endocrine disorders, contributing both to the scientific literature and clinical guidelines. His research interests extend to autoimmune thyroid disease and its systemic manifestations, as well as the metabolic complications of obesity and diabetes. He has also engaged in multidisciplinary collaborations, particularly in gastroenterology and internal medicine, reflecting the interconnected nature of chronic diseases. Beyond disease-specific research, he has contributed methodologically through systematic reviews, narrative reviews, and case reports, offering valuable evidence to inform clinical decision-making. His involvement as an editor and peer reviewer further underscores his commitment to ensuring quality in scientific publications. Ultimately, his research aims to bridge clinical practice with academic inquiry, improving patient care outcomes in endocrinology.

Awards and Honors

Dr. Marcio Jose Concepcion-Zavaleta has consistently been recognized for his academic excellence and scientific productivity. His most notable early achievement was graduating as valedictorian of his medical class at the Universidad Nacional de Trujillo, underscoring his academic dedication. His prolific research output, with more than 70 peer-reviewed publications, has earned him a strong reputation nationally and internationally. His active participation as a speaker and contributor in national and international medical conferences highlights his role in knowledge dissemination and professional leadership. He holds memberships in the American Society of Endocrinology and the Peruvian Society of Endocrinology, reflecting his engagement with professional communities. Furthermore, his editorial contributions to the World Journal of Gastroenterology (Q1) and the Electronic Journal of General Medicine (Q3) showcase his recognition by the international scientific community. These accomplishments affirm his status as a dedicated clinician-researcher committed to advancing endocrinology through scholarship, education, and professional collaboration.

Publication Top Notes

Conclusion

The researcher demonstrates a strong research profile, with a focus on endocrinology and a significant publication record. Their commitment to education and training, as well as their editorial experience, are notable strengths. With further development of international collaboration and publication in top-tier journals, they could become an even stronger candidate for the Best Researcher Award. Their contributions to the field of endocrinology and their potential for future research make them a strong contender for this award.

Prof. Shang-You Yang | biocompatibility | Best Researcher Award

Published on by Mechanics Awards

Prof. Shang-You Yang | biocompatibility | Best Researcher Award

Professor, University of Kansas School of Medicine, United States

The researcher is a dedicated academic and scientist with expertise in pharmaceutical research and biomaterials. As an international reviewer for several prestigious journals, they have demonstrated their commitment to advancing knowledge in their field.

Profile

scholar

🎓 Education

Although specific educational details are not provided, the researcher’s experience as an international reviewer suggests a strong foundation in pharmaceutical research or a related field. Their expertise in reviewing manuscripts for various journals indicates a high level of academic achievement.

👨‍🔬 Experience

– International Reviewer: Various journals, including Journal of Pharmaceutical Research International, Medicina, Molecular Medicine Reports, Aging and Disease, Bioengineering & Translational Medicine, International Journal of Molecular Sciences, and Polymers (2021-present)- The researcher has reviewed multiple manuscripts for these journals, demonstrating their expertise and commitment to advancing knowledge in their field.

🔍 Research Interest

– *Pharmaceutical Research*: Investigating various aspects of pharmaceuticals, including their development, application, and impact on human health.- *Biomaterials*: Exploring the properties and applications of biomaterials in medical research and development.

Awards and Honors🏆

No specific awards or honors are mentioned in the provided information. However, the researcher’s role as an international reviewer for several prestigious journals is a testament to their expertise and reputation in the field.

📚 Publications 

– Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization 🌟
– Inflammatory responses to orthopaedic biomaterials in the murine air pouch 🔬
– Diverse cellular and apoptotic responses to variant shapes of UHMWPE particles in a murine model of inflammation 💡
– Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells 🏥
– Effect of porosity and pore size on microstructures and mechanical properties of poly-ε-caprolactone-hydroxyapatite composites 🔍
– Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model 💊
– Murine model of prosthesis failure for the long-term study of aseptic loosening 🐭
– A novel murine model of orthopaedic wear-debris associated osteolysis 🔬

Conclusion

S.Y. Yang is a highly accomplished researcher with a strong background in biomaterials and tissue engineering. Their innovative research has contributed significantly to the understanding of complex topics, such as tissue-engineered bone regeneration and orthopedic implant loosening. With their consistent research output and interdisciplinary collaborations, Yang is an excellent candidate for the Best Researcher Award. Their research has the potential to improve human health outcomes, and their dedication to advancing knowledge in their field is evident in their publications.

Dr. Liang Yang | Bone biomaterials | Best Researcher Award

Published on by Mechanics Awards

Dr. Liang Yang | Bone biomaterials | Best Researcher Award

Dr at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Liang Yang, MD, is a 33-year-old orthopedic surgeon at Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, China. Specializing in biomimetic materials for orthopedic reconstruction, he focuses on repairing bone defects under pathological conditions like osteoporosis. His innovative work on hydroxyapatite (HA) modification and chiral-engineered biomaterials has led to significant advancements in bone healing and regeneration.

Publication Profile

orcid

🎓 Education

Liang Yang earned his MD in Orthopedics from Shanghai Jiao Tong University School of Medicine. His academic pursuits have centered on advancing orthopedic materials, particularly through modifying HA to enhance bioactivity. Yang’s education combined intensive clinical training with cutting-edge research on bioactive ion doping (Sr2+/Fe3+) in HA for bone regeneration, culminating in impactful publications and novel biomaterial development. His studies positioned him at the forefront of orthopedic biomimetics.

💼 Experienc

Dr. Yang has dedicated his career to orthopedic surgery and biomaterial research at Shanghai Sixth People’s Hospital. His expertise spans developing bioactive hydroxyapatite materials, pioneering chiral-engineered biomaterials, and addressing osteoporosis-induced bone defects. Yang has led multiple research projects, resulting in publications in high-impact journals. His work reflects a seamless blend of surgical practice and translational research, bridging the gap between clinical needs and innovative material solutions.

🏆 Awards and Honors

Dr. Yang’s contributions to orthopedic biomaterials have earned him recognition in scientific and medical communities. His publications in journals like Advanced Science and Chem. Eng. J. have been widely cited. He received institutional awards for innovation in biomimetic material development and recognition from Shanghai Jiao Tong University for advancing orthopedic reconstruction techniques. His groundbreaking work on chiral hydroxyapatite further positioned him as a leader in biomaterial innovation.

🔬 Research Focus

Liang Yang’s research focuses on biomimetic materials for orthopedic reconstruction, particularly hydroxyapatite (HA) modification to enhance bioactivity and bone regeneration. His work explores doping HA with Sr2+/Fe3+ ions to modulate immunoregulation, angiogenesis, and osteogenesis. Recently, Yang synthesized chiral hydroxyapatite (CHA) with enantiomer-dependent osseointegration properties, unveiling L-CHA’s superior potential for osteoporosis treatment. His research paves the way for next-gen chiral-engineered biomaterials in orthopedics.

Publications 📖

Chirality‐Induced Hydroxyapatite for Osteoporotic Osseointegration – Advanced Science, 2024. DOI: 10.1002/advs.202411602.

Focus: Enantioselective bone-implant interactions to enhance osseointegration in osteoporosis.

Graphene Oxide Quantum Dot Scaffold – Advanced Functional Materials, 2023. DOI: 10.1002/ADFM.202211709.

Focus: Immuno-inductive angiogenesis and nerve regeneration via biocompatible nanoscaffolds.

Cryogenically 3D Printed Biomimetic Scaffolds – Chemical Engineering Journal, 2022. DOI: 10.1016/J.CEJ.2021.133459.

Focus: Bone tissue engineering using Sr2+/Fe3+ doped hydroxyapatite scaffolds.

Biomimetic Porous Scaffolds – Biomedical Materials, 2022. DOI: 10.1088/1748-605X/ac4b45.

Focus: Accelerated angiogenesis/osteogenesis with doped hydroxyapatite.

3D Printed Porous Scaffolds for Bone Tissue – Biofabrication, 2021. DOI: 10.1088/1758-5090/ABCF8D.

Focus: Bioactive scaffolds enhancing bone regeneration.

Anterior Acetabular Fracture Fixation – BMC Musculoskeletal Disorders, 2021. DOI: 10.1186/S12891-021-04034-W.

Focus: Surgical fixation methods for acetabular fractures.

Cartilage Changes with Glucocorticoids – Cartilage, 2021. DOI: 10.1177/1947603520978574.

Focus: Epiphyseal cartilage effects in glucocorticoid-treated mice.

🔹 Conclusion

Dr. Liang Yang’s pioneering work in chiral hydroxyapatite and bioactive bone materials makes him a strong contender for the Best Researcher Award. His contributions to orthopedic biomaterials, innovative solutions for bone defects, and significant publication record underscore his potential to drive transformative advancements in orthopedic surgery and bone regeneration.